MagneGas Announces Additional Gasification Unit Sale of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
134
MagneGas Announces Additional Gasification Unit Sale of $1.58 Million for European Market

TAMPA, FL --(Marketwired - October 17, 2017) - MagneGas Corporation ("MagneGas" or the "Company") ( NASDAQ : MNGA ), a leading clean technology company in the renewable resources and environmental solutions industries, announced today the sale of an additional gasification unit for $1.58 million. The gasification unit will be placed in either the Nordics region for retail gas distribution or in a large steel mill in continental Europe to produce MagneGas2®. This order is an acceleration of the previously announced European consulting agreement. As a result of the newly formed consulting agreement with MagneGas, the European marketing partner has been able to accelerate certain business development opportunities in Europe beyond the immediate German market.

"This is an encouraging development for the Company and is part of the pipeline of unit placements we expect to deploy in the coming months and years in Europe," commented Ermanno Santilli, CEO of MagneGas. "This unit will either be placed in the Nordics region to produce MagneGas2® from Butanol or it will be placed in continental Europe at a large steel mill to produce MagneGas2® for exclusive use on-site. Ultimately, we expect both locations to become near term hubs for gas production beyond the primary German operations. Both opportunities are excellent and play into the strength of our propriety technology. Our partners and their blue-chip consultant's due diligence demonstrated a strong demand for MagneGas2® to replace acetylene due to its safer overall characteristics, its renewability and its improved performance."

"We were impressed by the quality of the opportunity pipeline that our distributor in Europe has developed in a relatively short period of time and this latest opportunity demonstrates continued success in penetrating a customer base which is ready for a replacement product to legacy acetylene," commented MagneGas CFO Scott Mahoney. "According to due diligence and discussions with our consulting partners, there is strong and immediate end market demand for our MagneGas2® core product in Europe. These innovative potential customers are attracted by the renewability of MagneGas2® and the desire to introduce a completely new operational opportunity to reduce their environmental impact while obtaining a more efficient and safer product."

About MagneGas Corporation

MagneGas® Corporation (MNGA) owns a patented process that converts various renewables and liquid wastes into MagneGas fuels. These fuels can be used as an alternative to natural gas or for metal cutting. The Company's testing has shown that its metal cutting fuel "MagneGas2®" is faster, cleaner and more productive than other alternatives on the market. It is also cost effective and safe to use with little changeover costs. The Company currently sells MagneGas2® into the metal working market as a replacement to acetylene.

The Company also sells equipment for the sterilization of bio-contaminated liquid waste for various industrial and agricultural markets. In addition, the Company is developing a variety of ancillary uses for MagneGas® fuels utilizing its high flame temperature for co-combustion of hydrocarbon fuels and other advanced applications. For more information on MagneGas®, please visit the Company's website at http://www.MagneGas.com .

The Company distributes MagneGas2® through Independent Distributors in the U.S and through its wholly owned distributor, ESSI (Equipment Sales and Services, Inc). ESSI has four locations in Florida and distributes MagneGas2®, industrial gases and welding supplies. For more information on ESSI, please visit the company's website at http://www.weldingsupplytampa.com .

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov .

Investor Contacts: Crescendo Communications T: 844-589-8760 mnga@crescendo-ir.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 527

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 116

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 350

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 63

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 554

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 356

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 270

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 462

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 284

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Large-Cap Stocks to Watch for Future Growth Opportunities

Updated Category News Views 409

Emerging Large-Cap Stocks: Evaluating Performance Last week proved to be a robust period for several large-cap stocks, demonstrating significant gains on the market. If you're looking to expand your portfolio with top performers, it's essential to keep an eye on these standout companies. AeroVironment's Spectacular Performance AeroVironment, Inc. (NASDAQ: AVAV) saw its...

Continue Reading
Celebrating 80 Years of Unity: Manchester Congress Reimagined

Updated Category News Views 373

Celebrating the Legacy of the Manchester Congress The Pan-African Progressive Front (PPF), working hand in hand with various organizations, has embarked on an exciting journey to commemorate the 80th anniversary of the historic Manchester Congress. This momentous event, pivotal in shaping pan-African unity and liberation movements, is set to stir conversations and inspire...

Continue Reading
Stifel Optimistic on Nurix's NX-5948 Ahead of ASH Presentation

Updated Category News Views 86

Stifel's Positive Adjustment for Nurix Therapeutics Stock Stifel, a well-known financial services firm, has shown renewed confidence in Nurix Therapeutics Inc. (NASDAQ: NRIX) by increasing its price target for the company’s shares from $30 to $34 while keeping a Buy rating. This optimistic outlook reflects anticipation surrounding Nurix's ongoing drug trials,...

Continue Reading
Josh Christie Steps Up as Chief Managing Partner at Ice Miller

Updated Category News Views 266

Josh Christie Steps Up as Chief Managing Partner at Ice Miller Ice Miller is excited to share that Joshua Christie will serve as its new Chief Managing Partner starting January 1, 2026. His election reflects the firm’s trust in his leadership capabilities and vision for the future. Based in the Indianapolis office, Christie has been an integral part of Ice Miller since...

Continue Reading
IPSEN's Latest Buy-Back Initiative: Weekly Summary Insights

Updated Category News Views 156

IPSEN's Buy-Back Program Overview IPSEN has embarked on an exciting buy-back program aimed at enhancing shareholder value by strategically purchasing its own shares. This initiative is not only an investment in its financial health but also reflects the confidence IPSEN has in its future. As of Week 33, 2025, a comprehensive overview of the transactions executed...

Continue Reading